BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 33573557)

  • 1. Use of Phenytoin, Phenobarbital Carbamazepine, Levetiracetam Lamotrigine and Valproate in Pregnancy and Breastfeeding: Risk of Major Malformations, Dose-dependency, Monotherapy vs Polytherapy, Pharmacokinetics and Clinical Implications.
    Kaplan YC; Demir O
    Curr Neuropharmacol; 2021; 19(11):1805-1824. PubMed ID: 33573557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
    Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy.
    Battino D; Tomson T; Bonizzoni E; Craig J; Perucca E; Sabers A; Thomas S; Alvestad S; Perucca P; Vajda F;
    JAMA Neurol; 2024 May; 81(5):481-489. PubMed ID: 38497990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal antiepileptic drug exposure and learning and memory functioning at 6 years of age: The NEAD prospective observational study.
    Cohen MJ; Meador KJ; May R; Loblein H; Conrad T; Baker GA; Bromley RL; Clayton-Smith J; Kalayjian LA; Kanner A; Liporace JD; Pennell PB; Privitera M; Loring DW;
    Epilepsy Behav; 2019 Mar; 92():154-164. PubMed ID: 30660966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis.
    Veroniki AA; Rios P; Cogo E; Straus SE; Finkelstein Y; Kealey R; Reynen E; Soobiah C; Thavorn K; Hutton B; Hemmelgarn BR; Yazdi F; D'Souza J; MacDonald H; Tricco AC
    BMJ Open; 2017 Jul; 7(7):e017248. PubMed ID: 28729328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antiepileptic drugs polytherapy on pregnancy outcomes in women with epilepsy: An observation study in northwest China.
    Shi X; Wang Y; Zhang Y; Song C; Jiang Y; Zhao J; Xia L; Ma L; Jiang W
    Epilepsy Behav; 2022 Oct; 135():108904. PubMed ID: 36095876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes.
    Veroniki AA; Cogo E; Rios P; Straus SE; Finkelstein Y; Kealey R; Reynen E; Soobiah C; Thavorn K; Hutton B; Hemmelgarn BR; Yazdi F; D'Souza J; MacDonald H; Tricco AC
    BMC Med; 2017 May; 15(1):95. PubMed ID: 28472982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies.
    Thangaratinam S; Marlin N; Newton S; Weckesser A; Bagary M; Greenhill L; Rikunenko R; D'Amico M; Rogozińska E; Kelso A; Hard K; Coleman J; Moss N; Roberts T; Middleton L; Dodds J; Pullen A; Eldridge S; Pirie A; Denny E; McCorry D; Khan KS
    Health Technol Assess; 2018 May; 22(23):1-152. PubMed ID: 29737274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognition after prenatal levetiracetam, lamotrigine, carbamazepine or valproate exposure.
    Huber-Mollema Y; van Iterson L; Oort FJ; Lindhout D; Rodenburg R
    J Neurol; 2020 Jun; 267(6):1724-1736. PubMed ID: 32112258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.
    Meador KJ; Baker GA; Browning N; Clayton-Smith J; Combs-Cantrell DT; Cohen M; Kalayjian LA; Kanner A; Liporace JD; Pennell PB; Privitera M; Loring DW;
    N Engl J Med; 2009 Apr; 360(16):1597-605. PubMed ID: 19369666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.
    Holmes LB; Mittendorf R; Shen A; Smith CR; Hernandez-Diaz S
    Arch Neurol; 2011 Oct; 68(10):1275-81. PubMed ID: 21670385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
    Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability.
    Bjørk MH; Zoega H; Leinonen MK; Cohen JM; Dreier JW; Furu K; Gilhus NE; Gissler M; Hálfdánarson Ó; Igland J; Sun Y; Tomson T; Alvestad S; Christensen J
    JAMA Neurol; 2022 Jul; 79(7):672-681. PubMed ID: 35639399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.
    Serafini A; Gerard E; Genton P; Crespel A; Gelisse P
    CNS Drugs; 2019 Mar; 33(3):195-208. PubMed ID: 30747367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.
    Harden CL; Pennell PB; Koppel BS; Hovinga CA; Gidal B; Meador KJ; Hopp J; Ting TY; Hauser WA; Thurman D; Kaplan PW; Robinson JN; French JA; Wiebe S; Wilner AN; Vazquez B; Holmes L; Krumholz A; Finnell R; Shafer PO; Le Guen C; ;
    Neurology; 2009 Jul; 73(2):142-9. PubMed ID: 19398680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiepileptic drugs as prophylaxis for postcraniotomy seizures.
    Greenhalgh J; Weston J; Dundar Y; Nevitt SJ; Marson AG
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD007286. PubMed ID: 32343399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative safety of antiepileptic drugs during pregnancy.
    Hernández-Díaz S; Smith CR; Shen A; Mittendorf R; Hauser WA; Yerby M; Holmes LB; ;
    Neurology; 2012 May; 78(21):1692-9. PubMed ID: 22551726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.
    Harden CL; Meador KJ; Pennell PB; Hauser WA; Gronseth GS; French JA; Wiebe S; Thurman D; Koppel BS; Kaplan PW; Robinson JN; Hopp J; Ting TY; Gidal B; Hovinga CA; Wilner AN; Vazquez B; Holmes L; Krumholz A; Finnell R; Hirtz D; Le Guen C; ;
    Neurology; 2009 Jul; 73(2):133-41. PubMed ID: 19398681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine.
    Martinez Ferri M; Peña Mayor P; Perez López-Fraile I; Escartin Siquier A; Martin Moro M; Forcadas Berdusan M;
    Neurologia (Engl Ed); 2018 Mar; 33(2):78-84. PubMed ID: 27452623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention rate of first antiepileptic drug in poststroke epilepsy: A nationwide study.
    Larsson D; Åsberg S; Kumlien E; Zelano J
    Seizure; 2019 Jan; 64():29-33. PubMed ID: 30529757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.